The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Don't be surprised if we get news of a wind powered, hydroelectric or solar powered cryptocurrency mining operation soon. If we can pull this off, expect a serious rerating of the company market cap.
Some interesting background information about Francesco from the CLP website:
"During the last twenty years, he has been Director of almost fifty companies in Italy, UK, USA, Israel, Hong Kong, China, Singapore, Mauritius and Jersey. Since 1984 to 2014, he has been Research Associate Professor at Udine, Milano and Siena University lecturing Artificial Intelligence, Theory and Application of Computation, and Virtual Reality. His academic papers include more than 50 individual and joint publications and three books on the subject of Artificial Intelligence as editor."
I think it's safe to say that in terms of computing endeavours, Francesco is more clued up than most and a lot of his experience will serve him well in identifying the best cyrptocurrency opportunities.
Some of you may not be aware of Francesco's previous involvement with the company "Wind Energy Italy Limited" and considering that we're exploring green ways of mining cyrptocurrencies, maybe a wind farm will give CLP a competitive advantage over some of the other cryptocurrency mining operations.
Notification of major holdings
I'm not sure why Cathal doesn't consider a share buy back? If ORPH could buy out Invesco Ltd at a sensible price it would be a good use of the existing cash we have?
Patiently waiting for that TR-1 RNS, it must be due anytime now.
According to the June 30th 2020 half year financial results, RMM had unaudited net assets of £29.3 million ($38.2 million USD).
The current market cap is approximately £6 million, so even with a potential placing the company has significant underlying asset value.
It seems that the ArcelorMittal steel plant was previously closed in 2016. I've found an article from August 2019 stating that MACCARI Steel Holdings Ltd had submitted a US $180 million bid for the plant but the liquidator had refused this offer.
https://newsday.co.tt/2019/08/28/maccari-optimistic-about-pt-lisas-steel-plant/
Apparently they were trying to get the Couva and Point Lisas Chambers of Commerce to intervene, with the hope that they could facilitate discussions between all parties and that a resolution could be found. So at this time, I'm unsure whether the steel plant is actually operating or not?
@observer842 - Thanks for the ship tracking links.
Apparently the Sider Venture cargo vessel was at Santana port in Brazil on the 12th of August and it arrived at the Point Lisas port in Trinidad and Tobago on the 15th of August. It's worth noting that Arcelor Mittal have the largest steelmaking plant in the Caribbean at Point Lisas (Trinidad) that produces direct reduced iron (DRI). So maybe that's where the Amapá iron ore stockpile will be processed?
According to Companies House filing history for Amigo Holdings PLC , Mr Jonathan Caldwell Roe was appointed as a director on 1 August 2020:
https://beta.companieshouse.gov.uk/company/10024479/filing-history/MzI3NDY5NDAxNmFkaXF6a2N4/document?format=pdf&download=0
I was looking through today's trading history for Amigo and noticed that there's just over £1.6 million in off-book trades? We can account for JB's 1% share sale at £378,983.56 but that still leaves just over £1.22 million in other off-book transactions. Does anyone else think this is really high? Are the MM's accumulating stock to fill some big orders?
Midatech Pharma - Clinical trials for MTX110:
* ClinicalTrials.gov Identifier: NCT04264143
* ClinicalTrials.gov Identifier: NCT03566199
* ClinicalTrials.gov Identifier: NCT04315064
https://clinicaltrials.gov/
I've just read TPI's research note from today and they estimate that MTPH has around £6 million in cash and the company's market cap is just over £7 million at present.
V-O-X-M-A-R-K-E-T-S
**********
Replace the ***** in the URL with "**********".
Midatech Pharma have an investor presentation on Thursday 18th June at 14:00 and those interested in participating should register their interest at:
https://**********.brand.live/c/midatech-pharma-investor-presentation
@AquaeSulis01 I think some of the patents that Midatech Pharma own might be attractive to Open Orphan, especially the ones surrounding mosquito-borne diseases like Zika. Midatech Pharma's existing patents have already been used in Flavivirus vaccine development like "EMX-001" which was targeting Dengue, Yellow fever and Zika.
http://emergexvaccines.com/wp-content/uploads/2018/08/August-2018-Emergex-Zika-White-Paper.pdf
Apart from that, I think Midatech Pharma has a lot of unrealised value in their proprietary drug delivery platform technologies (Q-Sphera, MidaSolve and MidaCore). Cathal Friel is the sort of chap who knows how to monetise these type of assets and extract maximum value from them.